Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2014
08/21/2014US20140237639 Soybean Variety XB02W13
08/21/2014US20140237636 Soybean Variety XB01Y13
08/21/2014US20140237632 Rapidly maturing fluroscent proteins and methods for using the same
08/21/2014US20140235933 Genetic modification of rats
08/21/2014US20140235847 METHODS, COMPOSITIONS, AND KITS FOR GENERATING rRNA-DEPLETED SAMPLES OR ISOLATING rRNA FROM SAMPLES
08/21/2014US20140235846 Polyelectrolyte-Coated Ion-Exchange Particles
08/21/2014US20140235844 Short Interfering RNA (siRNA) Analogues
08/21/2014US20140235832 Rank ligand polypeptides
08/21/2014US20140235815 Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing succinate related thereto
08/21/2014US20140235733 Plants expressing delta6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids
08/21/2014US20140235701 Ngf aptamer and application thereof
08/21/2014US20140235700 LENTIVIRAL VECTORS PSEUDOTYPED WITH MUTANT BaEV GLYCOPROTEINS
08/21/2014US20140235699 Adeno-parvovirus chimera with enhanced oncolytical potential
08/21/2014US20140235698 RNA Aptamer Specifically Binding to Carcinoembryonic Antigen and Use thereof
08/21/2014US20140235697 Micrornas in neurodegenerative disorders
08/21/2014US20140235696 Inhibition of microrna-134 for the treatment of seizure-related disorders and neurologic injuries
08/21/2014US20140235695 Modulation of hsp47 expression
08/21/2014US20140235694 Antisense modulation of ptp1b expression
08/21/2014US20140235693 Serpina1 sirnas: compositions of matter and methods of treatment
08/21/2014US20140235510 Microfluidic interface for highly parallel addressing of sensing arrays
08/21/2014US20140235509 Template directed split and mix synthesis of small molecule libraries
08/21/2014US20140235505 Rna array compositions and methods
08/21/2014US20140235498 Enhanced throughput mineral coatings for optimization of stem cell behavior
08/21/2014US20140235491 Method of applying etfb to abnormal proliferation of cell, and abnormal proliferation inhibitor
08/21/2014US20140235468 High throughput miniaturized assay system and methods
08/21/2014US20140235467 Protease-Resistant Systems for Polypeptide Display and Methods of Making and Using Thereof
08/21/2014US20140235453 Global transcription machinery engineering
08/21/2014US20140234975 Method for increasing the efficiency of double-strand-break induced mutagenesis
08/21/2014US20140234973 Generation of induced pluripotent stem cells from small volumes of peripheral blood
08/21/2014US20140234972 CRISPR-CAS Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes
08/21/2014US20140234971 Induction of Hemogenic Endothelium from Pluripotent Stem Cells
08/21/2014US20140234970 Modulation of stem cells using zinc finger proteins
08/21/2014US20140234969 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
08/21/2014US20140234967 Method to trigger rna interference
08/21/2014US20140234958 Gene delivery system and method of use
08/21/2014US20140234957 Engineered Cellular Pathways for Programmed Autoregulation of Differentiation
08/21/2014US20140234945 Transthyretin variants
08/21/2014US20140234944 Green Process for Producing Polyhydroxyalkanoates and Chemicals Using a Renewable Feedstock
08/21/2014US20140234937 Compositions and methods for the production of isoprene
08/21/2014US20140234933 EGVII Endoglucanase and Nucleic Acids Encoding the Same
08/21/2014US20140234930 Sorghum with increased sucrose purity
08/21/2014US20140234920 Variant thioesterases and methods of use
08/21/2014US20140234910 Methods for nucleic acid manipulation
08/21/2014US20140234908 Use of non-subtype b gag proteins for lentiviral packaging
08/21/2014US20140234904 Method for harvesting photosynthetic unicells using genetically induced flotation
08/21/2014US20140234903 Biosynthetic gene cluster for the production of peptide/protein analogues
08/21/2014US20140234902 Methods for producing modified glycoproteins
08/21/2014US20140234898 Protein and peptide libraries
08/21/2014US20140234893 Heterologous intron within an immunoglobulin domain
08/21/2014US20140234400 Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells
08/21/2014US20140234375 Compositions and Methods for Eliciting an Immune Response to Escape Mutants of Targeted Therapies
08/21/2014US20140234371 Modified gram positive bacteria and uses thereof
08/21/2014US20140234361 Novel expression vectors and uses thereof
08/21/2014US20140234359 Plant viral vaccines and therapeutics
08/21/2014US20140234352 B7-h3 and b7-h4, novel immunoregulatory molecules
08/21/2014US20140234348 Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
08/21/2014US20140234334 Peptides and related molecules that bind to tall-1
08/21/2014US20140234331 Human ctla-4 antibodies and their uses
08/21/2014US20140234326 Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of tm4sf4 in non-small cell lung cancer
08/21/2014US20140234321 Hunk, a snf1-related kinase essential for mammary tumor metastasis
08/21/2014US20140234320 Modulators of 4-1bb and immune responses
08/21/2014US20140234303 Treatment of neurological conditions
08/21/2014US20140234302 Methods and Compositions for Reducing Amyloid Beta Levels
08/21/2014US20140234299 Therapies for chronic renal failure using one or more integrin antagonists
08/21/2014US20140234285 Method for Therapeutic Angiogenesis
08/21/2014US20140234278 Compounds for improved viral transduction
08/21/2014US20140234275 Method for treating als via the increased production of factor h
08/21/2014US20140234274 Directed Evolution and In Vitro Panning of Virus Vectors
08/21/2014US20140234265 Compositions and method for manipulating pim-1 activity in circulatory system cells
08/21/2014US20140234256 Commensal Bacteria As Signal Mediators Within A Mammalian Host
08/21/2014DE112012004586T5 Pflanzen mit erhöhter Toleranz gegenüber Herbiziden Plants with increased tolerance to herbicides
08/21/2014DE102013101617A1 Mittel zur Selektion und/oder Erzeugung von gegen Gelbmosaikvirose resistenter Gerste Means for selection and / or generation of resistant against barley Gelbmosaikvirose
08/21/2014DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/20/2014EP2767592A1 Mutagenicity test method using mammalian cells
08/20/2014EP2767588A1 Use of rodent to produce hybrid antibodies contaning human variable region and rodent constant or FC region
08/20/2014EP2767161A1 Method for generating an non-human animal homozygous for a genetic modification
08/20/2014EP2766501A1 Nucleic acid amplification and use thereof
08/20/2014EP2766495A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases
08/20/2014EP2766488A1 Method of generating gene mosaics in eukaryotic cells
08/20/2014EP2766487A1 Plants with decreased activity of a starch dephosphorylating enzyme
08/20/2014EP2766486A1 Plants with decreased activity of a starch dephosphorylating enzyme
08/20/2014EP2766485A1 A nucleic acid assembly, vector, cell, methods and kit thereof
08/20/2014EP2766484A2 Regulation of receptor expression through delivery of artificial transcription factors
08/20/2014EP2766483A2 Methods and compositions for screening and treating developmental disorders
08/20/2014EP2766482A1 Micrornas in neurodegenerative disorders
08/20/2014EP2766481A1 Targeting of mirna precursors
08/20/2014EP2766480A1 Exon skipping therapy for dystrophic epidermolysis bullosa
08/20/2014EP2766479A1 Tricyclo-phosphorothioate dna
08/20/2014EP2766478A1 Novel asparaginase and methods for treating diseases associated with asparagine dependence
08/20/2014EP2766047A1 Methods
08/20/2014EP2766042A1 ANTIBODIES TO CD1d
08/20/2014EP2766041A1 Combinatorial compositions and methods of treating hemoglobinopathies
08/20/2014EP2765983A1 Composition for introducing nucleic acids into cells
08/20/2014EP2765982A1 Dimethyl sulfoxide as solvent for nucleic acids
08/19/2014US8812247 Method for achieving improved polypeptide expression
08/19/2014US8809653 Inbred corn line BC110
08/19/2014US8809652 Inbred corn line LM3
08/19/2014US8809651 Inbred corn line BB93
08/19/2014US8809650 Maize variety inbred PH1MHD
08/19/2014US8809638 Soybean cultivar BY0912931
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 4023